We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

1 hedge funds and large institutions have $1K invested in Genomic Health, Inc. in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FWM
Filbrandt Wealth Management
Wisconsin
+$1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FWM
1
Filbrandt Wealth Management
Wisconsin
$1K +$1K +15 New

GHDX Hedge Fund Activity: Q1 2020 in Review

1 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q1 2020, worth a combined $1K.

Buyers outnumbered sellers: 1 fund opened new GHDX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Filbrandt Wealth Management, opening a new position worth an estimated $1K.

  • 1 institutional investor held Genomic Health, Inc. (GHDX) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $1K of Genomic Health, Inc. stock for Q1 2020.
  • 1 fund opened new Genomic Health, Inc. positions in Q1 2020 and 0 closed out, a net change of +1 holder.
  • The largest Genomic Health, Inc. buyer in Q1 2020 was Filbrandt Wealth Management, an estimated $1K added.

Based on aggregated 13F filings for Q1 2020.